Received: 14 May 2020
Accepted: 30 December 2020
First Online: 16 January 2021
Ethics approval and consent to participate
: This study was approved in a meeting of Committee for Advanced Studies followed by Ethical Review Committee dated on: 07 March, 2019 (Ref: UAP/Pharm_CAS-ETA: 07_032019) of the Department of Pharmacy, University of Asia Pacific, further reviewed by ICDDR’B, Dhaka (International Center for Diarrhoeal Disease Research, Bangladesh) prior to the supply of laboratory animals (<i>Swiss albino</i> mice). Laboratory animals were maintained according to standard protocol (Guide for the Care and Use of Laboratory Animals, 8th Edition, National research Council, Washington DC, USA). Written informed consent was obtained from the volunteers from whom blood samples were withdrawn. Blood pressure was measured and history of taking any medications like antiplatelet/corticosteroid were taken and excluded if anyone had history of this.
: All the authors reviewed the manuscript and provide consent for publication.
: The authors declare that they have no competing interest.